Background:
Reductions in sperm quality due to free radical formation during cancer
chemotherapy are well documented, hence the need for an adjunct antioxidant
treatment during chemotherapy. This study was designed to investigate the
effects of N-acetylcysteine on sperm quality following cyclophosphamide
exposure in male Wistar rats.
Methods:
Twenty male Wistar rats weighing 150-170g were randomly assigned into 4
groups of five rats each, and were orally administered distilled water
(Control), Cyclophosphamide (6mg/kg), N-acetylcysteine (100mg/kg) or
Cyclophosphamide + N-acetylcysteine for 21 days. Sperm count,
histone-protamine replacement, chromatin integrity, testicular
histomorphometry and BAX Protein expression were assessed using standard
procedures. The data was presented as mean ± SEM and analyzed using
students' t- test. A
p
<0.05 was considered
significant.
Results:
Sperm counts were significantly reduced (
p
<0.05) among
the cyclophosphamide (69.95±7.78 x10
6
/ml) and
cyclophosphamide + N-acetylcysteine (64.78±3.52 x10
6
/ml)
treated rats, while it increased significantly (
p
<0.05)
in the N-acetylcysteine (132.20±28.71 x10
6
/ml) treated
rats compared to the control animals (115.30±8.70x10
6
/ml).
Increased interstitial space distance, degenerated Leydig cells and impaired
histone-protamine replacement observed among the cyclophosphamide-treated
rats were ameliorated in the cyclophosphamide + N-acetylcysteine-treated
rats. Sperm chromatin integrity, which was poor in the
cyclophosphamide-treated rats, was considerably improved when compared with
the Control and the N-acetylcysteine-treated rats. Bax protein expression
was reduced in the cyclophosphamide (20%) and
cyclophosphamide+N-acetylcysteine (20%) groups when compared with the
Control (50%) and N-acetylcysteine (50%) groups.
Conclusion:
We concluded that N-acetylcysteine might improve sperm histone protamine
replacement, which is one of the stage-specific effect of cyclophosphamide
toxicity.